LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

Search

STERIS PLC

Closed

SectorHealthcare

243.31 -0.53

Overview

Share price change

24h

Current

Min

237.55

Max

244.4

Key metrics

By Trading Economics

Income

400K

193M

Sales

36M

1.5B

P/E

Sector Avg

35.208

121.746

EPS

2.53

Dividend yield

0.95

Profit margin

12.887

Employees

17,787

EBITDA

-121M

269M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+20.42% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.95%

2.26%

Next Dividend date

19 mar 2026

Next Ex Dividend date

17 lut 2026

Market Stats

By TradingEconomics

Market Cap

-1.9B

24B

Previous open

243.84

Previous close

243.31

News Sentiment

By Acuity

74%

26%

324 / 352 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

STERIS PLC Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

4 lut 2026, 21:30 UTC

Earnings

Steris Sees FY Adj EPS $10.15-Adj EPS $10.30 >STE

4 lut 2026, 21:30 UTC

Earnings

Steris 3Q Rev $1.5B >STE

4 lut 2026, 21:30 UTC

Earnings

Steris 3Q Adj EPS $2.53 >STE

4 lut 2026, 21:30 UTC

Earnings

Steris 3Q Cont Ops EPS $1.96 >STE

5 lis 2025, 21:30 UTC

Earnings

Steris 2Q Cont Ops EPS $1.94 >STE

5 lis 2025, 21:30 UTC

Earnings

Steris 2Q Rev $1.5B >STE

5 lis 2025, 21:30 UTC

Earnings

Steris 2Q Adj EPS $2.47 >STE

6 sie 2025, 20:30 UTC

Earnings

Steris 1Q Adj EPS $2.34 >STE

6 sie 2025, 20:30 UTC

Earnings

Steris 1Q Rev $1.4B >STE

14 maj 2025, 20:30 UTC

Earnings

Steris Sees FY Adj EPS $9.90-Adj EPS $10.15 >STE

14 maj 2025, 20:30 UTC

Earnings

Steris 4Q Rev $1.5B >STE

14 maj 2025, 20:30 UTC

Earnings

Steris 4Q Adj EPS $2.74 >STE

Peer Comparison

Price change

STERIS PLC Forecast

Price Target

By TipRanks

20.42% upside

12 Months Forecast

Average 295.5 USD  20.42%

High 300 USD

Low 291 USD

Based on 4 Wall Street analysts offering 12 month price targets forSTERIS PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

4 ratings

2

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

225 / 226.35Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Strong Bullish Evidence

Sentiment

By Acuity

324 / 352 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
help-icon Live chat